All In Biotech

Drug Trial Radar · NCT03907176

Study of Post-Herniorrhaphy Non-opioid MMA Regimens

A Phase 3b, Randomized, Open-Label Study of HTX-011 as the Foundation of a Non-opioid, Multimodal Analgesic Regimen to Decrease Opioid Use Following Unilateral Open Inguinal Herniorrhaphy

Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

209

Actual

Start

Apr 4, 2019

Primary completion

Oct 25, 2021

Study completion Nov 22, 2021

Sponsor

Lead sponsor
Heron TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 8, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference for MMA regimen.

Conditions

  • Analgesia

Interventions

  • HTX-011Drug

    300 mg bupivacaine/9 mg meloxicam

  • Luer lock applicatorDevice

    Applicator for instillation

  • IbuprofenDrug

    600 mg

  • AcetaminophenDrug

    1 g

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Subjects Who do Not Receive an Opioid Prescription Through the Day 15 VisitTime frame: Through Day 15

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Anaheim Clinical Trials, LLC

    Anaheim, California

  • Horizon Clinical Research

    La Mesa, California

  • Sharp Grossmont Hospital

    La Mesa, California

  • University of California, Irvine Medical Center

    Orange, California

  • Parkview Community Hospital

    Riverside, California

  • Yale University School of Medicine

    New Haven, Connecticut

  • Medical Research of Westchester, Inc

    Miami, Florida

  • Professional Health Care of Pinellas

    St. Petersburg, Florida

  • University of Louisville Hospital

    Louisville, Kentucky

  • Baylor University Medical Center

    Dallas, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • Rutgers - New Jersey Medical School

    Newark, New Jersey

  • Stony Brook University Hospital

    Stony Brook, New York

  • Montefiore Hutchinson Campus

    The Bronx, New York

  • M3 Emerging Medical Research, LLC

    Durham, North Carolina

  • Cleveland Clinic Fairview

    Cleveland, Ohio

  • Cleveland Clinic

    Cleveland, Ohio

  • The Ohio State University Wexner Medical Center - University Hospital

    Columbus, Ohio

  • Midwest Clinical Research Center, LLC

    Dayton, Ohio

  • Summit Medical Group Oregon-Bend Memorial Clinic

    Bend, Oregon

  • Penn Presbyterian Medical Center

    Philadelphia, Pennsylvania

  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania

  • UPMC Shadyside Hospital

    Pittsburgh, Pennsylvania

  • UPMC Passavant

    Pittsburgh, Pennsylvania

  • Baylor University Medical Center

    Dallas, Texas

  • Hermann Drive Surgical Hospital

    Houston, Texas

  • Houston Methodist Hospital

    Houston, Texas

  • Plano Surgical Hospital

    Plano, Texas

  • Endeavor Clinical Trials, LLC

    San Antonio, Texas

  • JBR Clinical Research

    Draper, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.